ROCKWELL MEDICAL, INC. Other Receivables
ROCKWELL MEDICAL, INC. (RMTI) had Other Receivables of $6.26 million as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Nontrade Receivables
us-gaap:OtherReceivables · last filed 2023-03-30
- 2022-12-31: Other Receivables $6.26M.
- 2022-09-30: Other Receivables $7.37M.
- 2022-06-30: Other Receivables $8.09M.
- 2022-03-31: Other Receivables $7.12M.
| Period end | Other Receivables | Other Receivables as first filed |
|---|---|---|
| 2022-12-31 | $6.26M 10-K · filed 2023-03-30 | |
| 2022-09-30 | $7.37M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $8.09M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $7.12M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $5.91M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $6.04M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $5.36M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $6.60M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $4.17M 10-K · filed 2022-04-08 | |
| 2020-09-30 | $4.13M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $3.56M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $4.59M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $4.20M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $5.12K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $5.39K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $6.71K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $6.98M 10-K · filed 2020-03-17 | |
| 2018-09-30 | $7.59M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $5.36M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $5.68M 10-Q/A · filed 2018-08-14 | |
| 2017-12-31 | $6.36M 10-K · filed 2019-03-18 | $5.54M 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |